Skip to main content
. 2021 Nov 29;13(4):863–889. doi: 10.1039/d1sc05482a

Fig. 15. (a) Schematic illustration of the Fe1−xS-PVP-mediated gas/photothermal/chemodynamic synergistic therapy. Reproduced with permission from ref. 71. Copyright 2021, Wiley-VCH. (b) Schematic illustration of the enhanced Fenton reaction irradiated by NIR-II laser for the treatment of breast cancer. (c) PA images of tumors from 4T1 tumor-bearing mice treated with or without CS-GOD/CS-GOD@CM nanoparticles at different time points. (CS: Cu2−xSe, CM: tumor cell membrane). Reproduced with permission from ref. 72. Copyright 2020, Wiley-VCH. (d) In vitro FL images of PEG/LDNPs@CMSNs (copper/manganese silicate nanosphere (CMSN)-coated lanthanide-doped nanoparticles (LDNPs)) containing different concentrations and in vivo images of tumor-bearing mice under 980 nm laser irradiation. (e and f) In vitro T1-weighted MR (magnetic resonance) images of PEG/LDNPs@CMSNs and PBS and the corresponding relaxation rate r1versus concentration. (g) In vivo T1-weighted MR images of tumor-bearing mice treated with or without PEG/LDNPs@CMSNs. (h–i) In vitro and in vivo CT (computed tomography) images. Reproduced with permission from ref. 73. Copyright 2020, American Chemical Society.

Fig. 15